OBN Launch BioForward® Conference
Oxford, UK, 19th February 2018 / Sciad Newswire / OBN (UK) Ltd, the membership organisation supporting the life sciences industry, is delighted to announce the launch of BioForward, a unique, high-quality, international conference, focussed on creating and developing a practical roadmap for early stage, emerging, and developing companies to achieve sustainable business success and growth.
This new, annual event will provide life science companies with the knowledge, skills, connectivity, and support necessary to maximise their chances of success, helping to ensure their offerings get to market and beyond.
This one-day conference, organised by OBN in collaboration with Birmingham Health Partners, will take place in the Aston Webb Building at the University of Birmingham on Thursday 4th October 2018.
BioForward is aimed at professionals from early stage, emerging and developing life sciences companies who are keen to gain the knowledge, skills, connectivity, and support necessary to maximise their chances of success and efficiently navigate through the various development phases to market and beyond.
BioForward will feature:
- Panel discussions themed around the major challenges emerging companies face when developing biotech, pharmaceutical or medtech products, such as collaboration and open access, making the most of your financial resources, maximising your data assets and overcoming manufacturing challenges.
- A series of practical ‘How-to’ sessions, providing delegates with the opportunity to listen and interact with experts and influencers, thereby educating participants on applying the information shared in panel discussions to real-life business settings.
- An exhibition featuring specialists from preclinical and clinical development, manufacturing, quality, regulatory, human resources, IP, tax/investment/grants, business strategy and marketing.
- Opportunities for networking and partnering with fellow delegates.
John Harris, CEO of OBN, said: “As the leader of a growing life sciences company it is critical to make the right decisions at the right time, minimising risk and maximising the chance of success. BioForward provides an unrivalled environment to access the very best support and advice available, from a wide variety of sources. We are excited to be launching this event, and the level of interest already expressed emphasises that BioForward will be addressing a significant and unmet need in the sector.”
As well as venue sponsor, Birmingham Health Partners, we are pleased to announce that Merck is now confirmed as a Gold Sponsor of BioForward. This event will support their ongoing commitment to provide emerging R&D companies with leading innovations and solutions for today and the future.
For more information about the event including the full agenda, and details of how to get involved, please visit the website: www.bioforward.co.uk.
For further information, contact:
General Event Enquiries:
Head of Events, OBN
Head of Purchasing & Membership, OBN
PR & Media Enquiries:
Deborah Cockerill / Emma Pickup / Juliette Craggs
T: +44 (0)20 7470 8801
Notes to Editors
OBN is the membership organisation supporting and bringing together the UK’s emerging life sciences companies, corporate partners and investors. Our 400-member companies are located across the Golden Triangle and beyond with Birmingham, Nottingham, Manchester, the North East and Scotland, all benefiting from our networking, partnering, purchasing, advising and advocacy activities. www.obn.org.uk
OBN is also known for its delivery of BioTrinity (12th edition: 23 – 25 April 2018), Europe’s leading life sciences investment and biopartnering conference held annually in London. www.biotrinity.com
Further information about OBN’s tailored networking and partnering events, purchasing consortium, advice, consultancy services and advocacy activities is available on OBN’s website www.obn.org.uk.